Skip to content
Levomenol
Levomenol is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
purpleu baobab faceunapproved drug other2017-12-08
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
636 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD015179291227918227
Stomach neoplasmsD013274EFO_0003897C16153391356
AdenocarcinomaD000230722101136
ToxoplasmosisD014123EFO_0007517B58112
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8028241059
Pancreatic neoplasmsD010190EFO_0003860C2522348155
Rectal neoplasmsD01200413209141
LymphomaD008223C85.952010337
Colonic neoplasmsD003110C18101413135
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.051615234
LeukemiaD007938C9522010234
Esophageal neoplasmsD004938C158162124
Hiv infectionsD015658EFO_0000764B20528823
Pancreatic ductal carcinomaD02144177214
Show 32 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SarcomaD012509358
Cerebral toxoplasmosisD016781EFO_0007200B58.22215
Renal cell carcinomaD002292335
Central nervous system neoplasmsD0165431315
Ovarian neoplasmsD010051EFO_0003893C56224
Acinar cell carcinomaD018267224
OsteosarcomaD0125161314
Myelodysplastic syndromesD009190D46224
Bile duct neoplasmsD001650123
Biphenotypic leukemia acuteD015456C95.0133
Show 40 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A33
Non-small-cell lung carcinomaD00228933
Lung neoplasmsD008175C34.9033
Triple negative breast neoplasmsD06472622
Fallopian tube neoplasmsD00518522
Hepatitis cD006526B19.222
GlioblastomaD005909EFO_000051522
Myeloid leukemia acuteD015470C92.011
Squamous cell carcinoma of head and neckD00007719511
Peritoneal neoplasmsD01053411
Show 12 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Juvenile arthritisD001171EFO_0002609M0811
ObesityD009765EFO_0001073E66.911
Type 2 diabetes mellitusD003924EFO_0001360E1111
Appetitive behaviorD00107011
Healthy dietD00007200111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLEVOMENOL
INNlevomenol
Description
(-)-alpha-Bisabolol is a sesquiterpenoid.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1
Identifiers
PDB
CAS-ID23089-26-1
RxCUI1306126
ChEMBL IDCHEMBL1096927
ChEBI ID125
PubChem CID442343
DrugBankDB13153
UNII ID24WE03BX2T (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 30 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2,883 adverse events reported
View more details